References
- Narcotic Antagonists: Naltrexone Progress Repor, D. Julius, P. Renault. National Institute on Drug Abuse Research Monograph Series 9. U.S. Public Health Service, U.S. Government Printing Office, Washington, DC 1976
- Goldstein A. Heroin addiction: Sequential treatment employing pharmacologic supports. Arch. Gen. Psychiatr. 1976; 33: 353–358
- Himmelsbach D. K. Clinical studies of drug addiction. Physiological dependence, withdrawal and recovery. Arch. Inter. Med. 1942; 69: 766–772
- Martin W. R., Jasinski D. R. Physiological parameters of morphine dependence in man-tolerance, early abstinence, protracted abstinence. J. Psychiat. Res. 1969; 7: 9–17
- Wikler A. Conditioning factors in opiate addictions and relapse. Narcotic, D. M. Wilner, G. D. Kassebaum. McGraw-Hill, New York 1965; 85–100
- Sideroff S. I., Jarvik M. E. Conditioned responses to a videotape showing heroin related stimuli. Int. J. Addict., In Press
- O'Brien C. P., Chaddock B., Woody G., et al. Systematic extinction of narcotic drug use using narcotic antagonists. Psychosom. Med. 1974; 36: 458
- Meyer R. E., Mirin S. M., Altaian J. L. The clinical usefulness of narcotic antagonists: Implications of behavioral research. Am. J. Drug Alcohol Abus. 1975; 2: 417–432
- Greenstein R., O'Brien C., Mintz J., et al. Clinical experience with naltrexone in a behavioral research study: An interim report. Narcotic Antagonists: Naltrexone Progress Repor. National Institute on Drug Abuse Research Monograph Series 9. U.S. Public Health Service, U.S. Government Printing Office, Washington, DC 1976; 141–149
- Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists: Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Arch. Gen. Psychiatr. 1978; 35: 335–340
- Mirin S. M., Meyer R. E., McNamee H. B. Psychopathology, craving and mood during heroin acquisition: An experimental study. Int. J. Addict. 1976; 11: 525–544
- O'Brien C. P. Experimental analysis of conditioning factors in human narcotic addiction. Pharmacol. Rev. 1976; 27: 533–543
- Wikler A. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program. Narcotic Antagonists (Advances in Biochemical Psychopharmacolog), M. C. Braude, L. S. Harris, E. L. May. Raven, New York 1974; Vol. 8
- Sideroff S. Initiation of an ongoing naltrexone treatment program in methadone maintenance patients, newly detoxified patients, and post-addicts. Research Prospectu. Veterans Administration Hospital Brentwood, Los Angeles 1976
- Meyer R., Randall M., Barrington C., et al. Limitations of an extinction approach to narcotic antagonist treatment. Narcotic Antagonists: Naltrexone Progress Repor. National Institute on Drug Abuse Research Monograph Series 9. U.S. Public Health Service, U.S. Government Printing Office, Washington, DC 1976